J. B. Chemicals & Pharmaceuticals Limited

Symboli: JBCHEPHARM.NS

NSE

1743.85

INR

Markkinahinta tänään

  • 53.2431

    P/E-suhde

  • 8.4545

    PEG-suhde

  • 270.64B

    MRK Cap

  • 0.01%

    DIV Tuotto

J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM-NS) Tilinpäätöstiedotteet

Kaaviossa näet oletusarvot J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS). Yrityksen liikevaihto näyttää NaN M keskiarvon, joka on NaN % gowth. Koko jakson keskimääräinen bruttovoitto on NaN M, joka on NaN %. Keskimääräinen bruttovoittosuhde on NaN %. Yrityksen viime vuoden tuloksen nettotuloksen kasvu on NaN %, joka on NaN % % keskimäärin koko yrityksen historian aikana.,

Tase

J. B. Chemicals & Pharmaceuticals Limited verotukselliseen kehitykseen sukeltamalla havaitsemme keskimääräisen varallisuuden kasvun. Tämä korko on mielenkiintoisesti , mikä heijastaa sekä yrityksen huippuja että matalimpia lukemia. Neljännesvuosittaisessa vertailussa tämä luku on . Kun tarkastellaan viime vuotta taaksepäin, kokonaisvarojen muutos on NaN. Osakkeenomistajien arvo, jota kuvaa osakepääoman kokonaismäärä, arvostetaan NaN raportointivaluutassa. Tämän näkökohdan vuosittainen muutos on NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

balance-sheet.row.cash-and-short-term-investments

02928.6566.56936.6
3628.2
3960.5
4117.1
2337.1
2072.5
5723.6
5058.1
4117
5184.5
1950
1375.4
1018.4
750.9
577
381

balance-sheet.row.short-term-investments

02159.31.16649.7
3338.1
3606.5
3837.7
2249.6
1952.5
5559.5
4972.6
3979.8
2989.2
681.1
596.8
580
601.3
373.1
265

balance-sheet.row.net-receivables

05771.76238.84186.7
3613.5
4068.4
4215.6
2726.7
29.6
16.9
32.5
4274.7
1360.5
0
0
3028
3224.2
0
0

balance-sheet.row.inventory

04304.94099.63474.5
2746.7
2437.6
2137.3
2001.7
1879.8
1502.7
1344
1045.3
1010.3
1116.7
834.7
807.7
746.9
835.7
643.1

balance-sheet.row.other-current-assets

02275.11843.6928.2
4352.4
29.3
0
883.4
3795.7
3586.9
3371.8
0
1106.8
3455.8
3448.2
0
0
3133.1
2526.5

balance-sheet.row.total-current-assets

015280.312748.515526
10727.3
10495.8
10470
7948.9
7777.6
10830.2
9806.5
9437.1
8662.2
6522.5
5658.4
4854.2
4722.1
4545.8
3550.6

balance-sheet.row.property-plant-equipment-net

05764.25668.25696.6
5842
5595.1
5811.1
6010.3
5019
3590.6
3316.2
3001.1
2791.9
2446.6
2263.8
2327.1
2443
2333.1
1473

balance-sheet.row.goodwill

0574.6574.6574.6
531.4
531.4
531.4
531.4
531.4
169
169
169
0
169
169
169
169
169
0

balance-sheet.row.intangible-assets

013222.86713.9321.1
300.9
233.8
226.5
290.3
162.3
77.8
83.8
221.1
360.4
4.7
34.9
37.1
3.7
0.1
0

balance-sheet.row.goodwill-and-intangible-assets

013797.47288.5895.6
832.3
765.2
757.9
821.7
693.7
246.8
252.8
390.1
360.4
173.7
204
206.1
172.7
169.1
0

balance-sheet.row.long-term-investments

0137.8127.2129.1
694.5
958.8
-3336.6
-337.7
-104.2
-5461.1
-4945
-3916.8
-2959.3
168.7
-354.1
-505.1
-526.1
-298.3
-236

balance-sheet.row.tax-assets

065.164.369.4
39.5
203.1
368.9
2264.1
2187.8
-246.8
-252.8
4090.4
2989.2
681.1
596.8
580
601.3
373.1
0

balance-sheet.row.other-non-current-assets

0493.9177.264.4
0
-107.9
3577.5
33.1
0
5912.8
5332.5
0.2
133.5
1.2
0.8
0.8
0
0.1
265.1

balance-sheet.row.total-non-current-assets

020258.413325.56855.1
7408.3
7414.3
7178.9
8791.5
7796.3
4042.3
3703.7
3564.9
3315.8
3471.3
2711.3
2608.9
2691
2577.1
1502.1

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

035538.72607422381.2
18135.6
17910
17648.9
16740.4
15573.8
14872.5
13510.1
13002
11978
9993.8
8369.7
7463.1
7413.1
7122.9
5052.8

balance-sheet.row.account-payables

02386.42244.81869.2
1237.9
827.6
1104
989.8
908.5
775.1
607.5
605.1
370.9
504.5
455
386.6
441.5
634.8
258.7

balance-sheet.row.short-term-debt

01739.1339.4398.5
369.9
258
292.9
488.6
1930.2
1266.2
813.9
368.8
552.3
0
0
0
0
0
0

balance-sheet.row.tax-payables

049.560.979
60.2
39.4
1.5
8.7
3665
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

03985.4206.251.4
12.3
35.3
60.7
86.1
0
4
0.9
2.2
125.5
1690.6
1367.6
1787.7
1963.5
1743.7
956.3

Deferred Revenue Non Current

0152.131.749.3
59.7
22
36
39.5
0
116.3
121.9
152.5
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0236.588.299.4
16.5
7.1
0
0
220
2.4
91.6
70.7
787.5
720.6
707.4
471.5
323
374.9
379.9

balance-sheet.row.total-non-current-liabilities

05190.7850.7794.1
627.2
648.4
456.6
269.8
262.6
326.2
319.3
409.6
395.2
1853.3
1526.1
1916.1
2118.3
1928.6
1110.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0242.1282.4123.4
61.8
12.3
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

010735.24687.94246.9
3755.7
3080.7
3205.6
3081.9
4620.6
4923.7
3082
2799.3
2278.5
3078.4
2688.5
2774.2
2882.8
2938.3
1749

balance-sheet.row.preferred-stock

0000
20913.2
22450.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0154.8154.6154.6
154.6
160.5
167.1
169.6
169.6
169.6
169.5
169.4
169.4
169
168.7
168.7
168.7
168.7
160.7

balance-sheet.row.retained-earnings

022757.118427.115847.9
12329.5
11024.3
9291.2
8066.1
5405.7
4312.3
4792.5
4543.5
4134.1
6746.4
5512.5
4520.3
4361.6
4015.9
3143

balance-sheet.row.accumulated-other-comprehensive-income-loss

02698.82248.41583.6
-5154.1
-4534.5
-4045.8
-3503.1
-3058.1
-2664.6
-2244.6
-1984.9
-1761.5
-1581.3
-1398.9
-1198.6
-1006.3
-839.4
-722.9

balance-sheet.row.other-total-stockholders-equity

0-807.1511.2511.2
-13888.3
-14299.2
9003.1
8904
8420.1
8131.5
7710.7
7474.7
7157.5
1581.3
1398.9
1198.6
1006.3
839.5
722.9

balance-sheet.row.total-stockholders-equity

024803.521341.218097.2
14354.9
14801.2
14415.6
13636.7
10937.3
9948.7
10428.1
10202.7
9699.5
6915.4
5681.2
4688.9
4530.2
4184.6
3303.8

balance-sheet.row.total-liabilities-and-stockholders-equity

035538.72607422381.2
18135.6
17910
17648.9
16740.4
15573.8
14872.5
13510.1
13002
11978
9993.8
8369.7
7463.1
7413.1
7122.9
5052.8

balance-sheet.row.minority-interest

0044.937.1
25
28
27.7
21.8
16
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

024803.521386.118134.3
14379.9
14829.3
14443.3
13658.5
10953.3
9948.7
10428.1
10202.7
9699.5
6915.4
5681.2
4688.9
4530.2
4184.6
3303.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0323.9128.1130.9
695.9
960.3
501.1
1923.3
1848.3
28.3
28.4
29.9
30
849.8
242.7
74.9
75.2
74.9
29

balance-sheet.row.total-debt

05724.5545.6449.9
382.2
258
292.9
488.6
1930.2
1266.2
814.8
370.9
677.7
1690.6
1367.6
1787.7
1963.5
1743.7
956.3

balance-sheet.row.net-debt

04955.2-19.9163
92.1
-96
13.5
401.2
1810.2
1102.1
729.3
233.7
-1517.6
421.7
588.9
1349.2
1813.9
1539.8
840.3

Kassavirtalaskelma

J. B. Chemicals & Pharmaceuticals Limited taloudessa on tapahtunut huomattava muutos vapaan kassavirran määrässä viimeisen ajanjakson aikana, ja se on muuttunut NaN suuntaan. Yhtiö on hiljattain laajentanut osakepääomaansa laskemalla liikkeeseen NaN, mikä merkitsee NaN eroa edelliseen vuoteen verrattuna. Yhtiön investointitoiminnasta aiheutui nettokassan käyttöä, joka oli NaN raportointivaluutassa. Tämä on NaN siirtymä edellisestä vuodesta. Samana ajanjaksona yhtiö kirjasi NaN, NaN ja NaN, jotka ovat merkittäviä yrityksen investointi-ja takaisinmaksustrategioiden ymmärtämisen kannalta. Yhtiön rahoitustoiminta johti siihen, että nettokassan käyttö oli NaN, ja ero edellisvuoteen oli {{year_over_year_net_cash_from_financing_activities_change_percentage}}. Lisäksi yhtiö osoitti NaN osingonjakoon osakkeenomistajilleen. Samaan aikaan se toteutti myös muita rahoitusmanöövereitä, joihin viitataan nimellä {{other-financing-activities}}, jotka myös vaikuttivat merkittävästi sen kassavirtaan kyseisenä ajanjaksona. Nämä osatekijät muodostavat yhdessä kattavan kuvan yrityksen taloudellisesta tilanteesta ja strategisesta lähestymistavasta kassavirran hallintaan.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

cash-flows.row.net-income

05552.350495968.9
3488.9
2869.9
1939.5
2299.4
2088.2
1455.5
874.5
1035.7
8434.4
1653.4
1480.7
370.6
436.9
827
662.1

cash-flows.row.depreciation-and-amortization

01144.1726.6686.7
663.2
556.4
569.7
472.2
412.4
386.4
280.2
246.6
224.2
227.9
215.7
204.3
169
107.3
104.9

cash-flows.row.deferred-income-tax

0-1146.7-1685.90
0
0
0
0
0
0
0
0
0
0
-293.2
-113.5
111.7
0
0

cash-flows.row.stock-based-compensation

0693.7626.50
0
0
0
0
0
0
0
0
0
0
0
0
0.6
0
0

cash-flows.row.change-in-working-capital

0-299.2-3025.2-942.1
93.2
-519.5
-478.3
27.7
-173.3
-195.2
-937.1
94.7
1673.5
-158.7
-227.7
17.5
-427.3
-623.6
-433.2

cash-flows.row.account-receivables

0-417.5-2928.4-706
-115
-138.8
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-205.2-625.1-700.9
-309.1
-300.3
-135.6
-121.9
-179.5
-158.7
-298.7
-35
106.4
-282
-27
-60.8
88.8
-115.2
-97.7

cash-flows.row.account-payables

0323.5528.3464.8
521.1
-285.7
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
-3.8
205.2
-342.6
149.6
6.2
-36.5
-638.4
129.7
1567.1
123.3
-200.8
78.3
-516.1
-508.4
-335.5

cash-flows.row.other-non-cash-items

0311.910.3-2565.6
-1491.7
-976
-800.5
-797.4
-930.6
-380
-357.4
-527.7
-1535.2
-384.4
44.3
432.2
-7.8
-87.8
-108.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-7649.5-7067.9-477.7
-729.7
-483.4
-365.6
-1561.7
-1994.6
-711.9
-603.9
-492.1
-801
-343.6
-126.3
-157
-284.6
-235.5
-178.9

cash-flows.row.acquisitions-net

01998.6-7003.9-85
65.5
105
97.4
12.9
-523
16.8
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-7568.7-5084.7-5412.1
-3826.8
-4252.3
-4200.6
-1834.5
-1993
-2460.8
-3913
-6018.1
-17174.2
-4578.7
-207.6
-0.6
-0.3
-1.8
-2.1

cash-flows.row.sales-maturities-of-investments

05570.112088.63169.1
4739.3
4356
4234
2920.9
4045.5
2036.9
3070.5
5290
15022.9
3976.9
26.4
0
0
2.5
0.6

cash-flows.row.other-investing-activites

0-1968.47091.1498.9
-5.4
5.8
26.6
26.9
144.8
0
21.5
59.7
343.1
50.8
12.9
14.5
4.3
9.3
7.1

cash-flows.row.net-cash-used-for-investing-activites

0-9617.923.2-2306.8
243
-268.9
-208.1
-435.5
-320.3
-1118.9
-1425
-1160.5
-2609.2
-894.6
-294.6
-143.1
-280.6
-225.6
-173.3

cash-flows.row.debt-repayment

0-872.5-3.3-3.2
-63.1
-0.5
0
0
-0.9
-1.3
-1.2
-177.2
-1019.5
-248.6
-486.6
-429.4
-313.6
-49.1
-35.5

cash-flows.row.common-stock-issued

084.800
-63.1
0.5
0
0
1.1
7.1
2.1
0
15.8
14.9
0
0
0
4.6
0

cash-flows.row.common-stock-repurchased

05684.800
-1608.2
-1310.3
-500
0
665.7
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-1275.9-1275.6-732.4
-1410
-207.9
-103.4
-57.4
-1875.4
-297.2
-298.3
-99.9
-4121.8
-196.5
-98.4
-49.6
-148
-228.4
-208.3

cash-flows.row.other-financing-activites

0-55.8-105-138.6
84
-34.7
8.1
-1771.7
13.7
277.5
417.9
-44.8
-135.7
476.9
0
0
404.9
296.8
228.3

cash-flows.row.net-cash-used-provided-by-financing-activities

03565.4-1383.9-874.2
-3060.5
-1552.9
-595.2
-1829
-1195.8
-13.9
120.4
-321.8
-5261.2
46.6
-584.9
-479.1
-56.7
23.9
-15.4

cash-flows.row.effect-of-forex-changes-on-cash

00.300.4
-0.1
-0.2
0
0
17.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0203.9340.7-32.8
-63.9
109
427.2
-262.6
-102.3
133.8
-1444.3
-633
926.5
490.2
340.2
288.8
-54.2
21.1
36.8

cash-flows.row.cash-at-end-of-period

0769.3565.4224.7
257.5
321.4
212.4
-168.3
149.6
251.9
118.1
1562.3
2195.3
1268.9
778.6
438.5
149.6
116
94.9

cash-flows.row.cash-at-beginning-of-period

0565.4224.7257.5
321.4
212.4
-214.7
94.2
251.9
118.1
1562.3
2195.3
1268.9
778.6
438.5
149.6
203.9
94.9
58.1

cash-flows.row.operating-cash-flow

06256.11701.33147.8
2753.7
1930.8
1230.5
2002
1396.7
1266.6
-139.8
849.3
8796.9
1338.2
1219.7
911.1
283.1
222.8
225.5

cash-flows.row.capital-expenditure

0-7649.5-7067.9-477.7
-729.7
-483.4
-365.6
-1561.7
-1994.6
-711.9
-603.9
-492.1
-801
-343.6
-126.3
-157
-284.6
-235.5
-178.9

cash-flows.row.free-cash-flow

0-1393.4-5366.52670.1
2024
1447.3
864.9
440.3
-598
554.8
-743.7
357.2
7995.9
994.6
1093.4
754
-1.5
-12.7
46.6

Tuloslaskelmarivi

J. B. Chemicals & Pharmaceuticals Limited liikevaihto muuttui NaN% edelliseen kauteen verrattuna. JBCHEPHARM.NS:n bruttovoitto ilmoitetaan NaN. Yrityksen toimintakulut ovat NaN, ja niissä on tapahtunut NaN%:n muutos edelliseen vuoteen verrattuna. Poistojen ja arvonalentumisten kulut ovat NaN, mikä on NaN% muutos edellisestä tilikaudesta. Toimintakulujen ilmoitetaan olevan NaN, mikä osoittaa NaN%:n muutoksen edellisvuoteen verrattuna. Myynti- ja markkinointikulut ovat NaN, mikä on NaN% muutos edelliseen vuoteen verrattuna. Viimeisimpiin lukuihin perustuva käyttökate on NaN, mikä vastaa NaN%:n kasvua edellisvuoteen verrattuna. Liikevoitto on NaN, joka osoittaa NaN%:n muutosta edelliseen vuoteen verrattuna. Nettotuloksen muutos on NaN%. Viime vuoden nettotulos oli NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

income-statement-row.row.total-revenue

031492.824242.420058.5
17427
16102.3
13851.2
13103.9
11681.9
10487.6
9386.2
7858.4
8018.7
8416.3
7409.7
7170.9
5624
5255.7
4657

income-statement-row.row.cost-of-revenue

03842.28633.77174.4
6542.7
6213.2
5617
5523.8
5198.5
4751.2
4349.2
3829.6
3598.9
2739.7
-32.2
58.5
83.9
-7.3
-57

income-statement-row.row.gross-profit

027650.615608.712884.1
10884.4
9889.1
8234.2
7580.1
6483.4
5736.3
5037
4028.8
4419.8
5676.6
7441.9
7112.4
5540.1
5263.1
4714

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

099.48.476.2
67.8
24.5
58.3
62.8
7
5532.4
177.5
11.9
-84.5
4218.7
5961.2
6741.8
5103.2
4551.5
3887

income-statement-row.row.operating-expenses

013997.410862.78009.7
7704.8
7305.7
6615.8
5739
5008
4571.4
4148.3
3526.1
3263.9
4218.7
5961.2
6741.8
5103.2
4551.5
3887

income-statement-row.row.cost-and-expenses

03842.219496.515184.1
14247.4
13518.9
12232.8
11262.8
10206.5
9322.6
8497.5
7355.7
6862.8
6958.5
5929
6800.3
5187.2
4544.2
3830

income-statement-row.row.interest-income

025.49.317.7
28.5
23
16.8
11.8
11
13.3
13.2
12.6
85.6
0
0
0
0
0
0

income-statement-row.row.interest-expense

0360.547.969.4
29.2
38.7
31.4
49.1
22.1
33.5
27.1
38.6
240.3
104.9
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-365.6310.11073.4
306.8
287.4
263.2
345.8
123.3
40.7
-333.5
-19.6
7278.6
195.5
0
0
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

099.48.476.2
67.8
24.5
58.3
62.8
7
5532.4
177.5
11.9
-84.5
4218.7
5961.2
6741.8
5103.2
4551.5
3887

income-statement-row.row.total-operating-expenses

0-365.6310.11073.4
306.8
287.4
263.2
345.8
123.3
40.7
-333.5
-19.6
7278.6
195.5
0
0
0
0
0

income-statement-row.row.interest-expense

0360.547.969.4
29.2
38.7
31.4
49.1
22.1
33.5
27.1
38.6
240.3
104.9
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

01144.1726.6686.7
663.2
556.4
569.7
472.2
412.4
386.4
280.2
246.6
224.2
227.9
215.7
204.3
169
107.3
104.9

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

05917.947394895.4
3182.2
2582.6
1676.3
2299.4
2088.2
1455.5
874.5
1035.7
1330.5
1457.9
1480.7
370.6
436.9
711.5
827

income-statement-row.row.income-before-tax

027650.650495968.9
3488.9
2869.9
1939.5
2299.4
2088.2
1455.5
874.5
1035.7
8434.4
1653.4
1480.7
370.6
436.9
711.5
827

income-statement-row.row.income-tax-expense

0893.11188.61483.6
765
930.2
552.3
455.5
469.1
451.4
259.5
241.3
1655.3
260.2
293.2
113.5
16.3
89.8
124.6

income-statement-row.row.net-income

04098.33853.64479.6
2720.5
1934.7
1383.4
1840.6
1618.8
1004.1
615
794.4
6779.1
1393.2
1187.5
257.1
453.2
621.8
702.4

Usein kysytty kysymys

Mikä on J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) taseen loppusumma?

J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) kokonaisvarat ovat 35538700000.000.

Mikä on yrityksen vuotuinen liikevaihto?

Vuotuinen liikevaihto on N/A.

Mikä on yrityksen voittomarginaali?

Yrityksen voittomarginaali on 0.890.

Mikä on yrityksen vapaa kassavirta?

Vapaa kassavirta on 14.157.

Mikä on yrityksen nettovoittomarginaali?

Nettovoittomarginaali on 0.152.

Mikä on yrityksen kokonaistulot?

Kokonaisliikevaihto on 0.855.

Mikä on J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) nettovoitto (nettotulos)?

Nettovoitto (nettotulos) on 4098300000.000.

Mikä on yrityksen kokonaisvelka?

Kokonaisvelka on 5724500000.000.

Mikä on yrityksen toimintakulujen määrä?

Toimintakulut ovat 13997400000.000.

Mikä on yrityksen kassan määrä?

Yrityksen kassavarat ovat 0.000.